InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (14 ops.)
Insider track record
ExecutiveDisclosed buys
0
Disclosed sells
14
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Discover the detailed record of transactions filed by Boyer David W., Directeur des Affaires Corporatives. Insider active across 1 company, notably Neurocrine Biosciences INC. Cumulatively, 19 disclosures have been recorded. Split: 0 buy · 14 sells. Total volume traded: €2.2m. Activity tracked since 7 February 2022. The latest transaction was disclosed on 26 May 2026 (Cession). Regulator: SEC (Form 4). The full history is openly available.
Companies and markets linked to Boyer David W.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations19 total
3,888 shares@ US$156.64180.0033% mcap23.3% of flowCommon StockSEC:0001909817-26-000007:0
1,600 shares0Common StockSEC:0001909817-26-000005:0
2,096 shares0Common StockSEC:0001909817-26-000003:0
1,811 shares0Common StockSEC:0000914475-25-000059:0
1,329 shares0Common StockSEC:0000914475-25-000048:0
2,096 shares0Common StockSEC:0000914475-25-000023:0
1,295 shares@ US$113.665.9% of flowCommon StockSEC:0000914475-24-000203:0
3,461 shares@ US$121.880417.0% of flowCommon StockSEC:0000914475-24-000201:0
955 shares@ US$133.09565.3% of flowCommon StockSEC:0000914475-24-000069:0
240 shares@ US$141.961.4% of flowCommon StockSEC:0000914475-24-000051:0
1,104 shares@ US$140.87296.4% of flowCommon StockSEC:0000914475-24-000024:0
1,437 shares@ US$112.686.9% of flowCommon StockSEC:0001209191-23-052028:0
1,295 shares@ US$106.905.6% of flowCommon StockSEC:0001209191-23-047968:0
1,600 shares@ US$107.41387.0% of flowCommon StockSEC:0001209191-23-047132:0
240 shares@ US$105.6091.0% of flowCommon StockSEC:0001209191-23-007909:0
1,104 shares@ US$109.91725.0% of flowCommon StockSEC:0001209191-23-006263:0
1,295 shares@ US$114.126.6% of flowCommon StockSEC:0001209191-22-055389:0
1,437 shares@ US$106.596.9% of flowCommon StockSEC:0001209191-22-052896:0
240 shares@ US$81.070.0001% mcap50.0% of flowCommon StockSEC:0001209191-22-008250:0
19 of 19 declarations
About Boyer David W.
David W. Boyer is the Chief Corporate Affairs Officer at Neurocrine Biosciences Inc. He is responsible for the company's communication strategy and public relations. His role is essential in enhancing brand image and managing stakeholder relationships.
